Summary
The present study compared the effects of amrinone, dobutamine, dibutyryl cAMP, digoxin, and isoproterenol on mechanical performance, the high energy phosphate metabolites, and the [Ca2+]i transients in normal and cardiomyopathic hamster hearts with severe heart failure. In normal hearts dobutamine, dibutyryl cAMP, and isoproterenol increased left ventricular developed pressure, while amrinone and digoxin did not. However, the amplitude of [Ca2+]i transients was augmented with all drugs. Diastolic [Ca2+]i level was increased with dobutamine and lowered with dibutyryl cAMP and isoproterenol. In cardiomyopathic hearts with severe heart failure, left ventricular developed pressure, the amplitude of [Ca2+]i transients, the phosphorylation potential, and [cAMP]i were significantly depressed and left ventricular end-diastolic pressure and diastolic [Ca2+]i were significantly elevated when compared with normal hearts. Amrinone, dibutyryl cAMP, and isoproterenol improved mechanical performance while increasing [cAMP]i and the amplitude of [Ca2+]i transients, and decreasing diastolic [Ca2+]i. On the other hand, with dobutamine and digoxin diastolic [Ca2+]i was further increased and mechanical performance deteriorated with digoxin. Thus, distinct differences exist in modulation of mechanical performance, high-energy phosphate metabolism, and [Ca2+]i transients by positive inotropic drugs between normal and cardiomyopathic hearts with severe heart failure.
Similar content being viewed by others
References
Sievers R, Parmley WW, James T, Wikman-Coffelt J. Energy levels at systole vs. diastole in normal hamster heart vs. myopathic hamster heart.Circ Res 1983;53:759–766.
Wikman-Coffelt J, Sievers R, Parmley WW, Jasmin G. Cardiomyopathic and healthy acidotic hamster hearts: Mitochondrial activity may regulate cardiac performance.Cardiovasc Res 1986;20:471–481.
Camacho SA, Wikman-Coffelt J, Wu ST, et al. Improvement in myocardial performance without a decrease in high energy phosphate metabolites after isoproterenol in Syrian cardiomyopathic hamsters.Circulation 1988;77:712–718.
Kapelko V, Parmley WW, Wu ST, Jasmin G, Wikman-Coffelt J. Increased left ventricular diastolic stiffness in the early phase of hereditary cardiomyopathy.Am Heart J 1988;116:765–770.
Wikman-Coffelt J, Stefenelli T, Wu ST, Parmley WW, Jasmin G. [Ca2+]i transients in the cardiomyopathic hamster heart.Circ Res 1991;68:45–51.
Auffermann W, Wu ST, Parmley WW, Wikman-Coffelt J. Glycolysis in heart failure: A31P-MRS and surface fluorometry study.Basic Res Cardiol 1990;85:342–357.
Wikman-Coffelt J, Auffermann W. Influence of drugs on diseased states of the heart: A31P-MRS and [Ca2+]i study.Invest Radiol 1989;24:976–979.
Markiewicz W, Wu ST, Parmley WW, Higgins CB, Wikman-Coffelt J. Influence of heart rate on metabolic and hemodynamic parameters in the Syrian hamster cardiomyopathy.Am Heart J 1987;114:362–368.
Buser P, Wu ST, Jasmin G, Parmley WW, Wikman-Coffelt J. Dobutamine potentiates amrinone's beneficial effects in moderate but not in advanced heart failure.Circ Res 1990;66:747–753.
Wikman-Coffelt J, Sievers R, Coffelt RJ, Parmley WW. Biochemical and mechanical correlates at peak systole in myopathic Syrian hamsters. In: Jacob R, ed.Cardiac Adaptation to Hemodynamic Overload, Training and Stress. Tübingen: Steinkopf Verlag, 1983:197–203.
Kessler PD, Cates AE, VanDop C, Feldman AM. Decreased bioactivity of the guanine nucleotide-binding protein that stimulates adenylate cyclase in hearts from cardiomyopathic Syrian hamsters.J Clin Invest 1989;84:244–252.
Feldman MD, Copelas L, Gwathmey JK, et al. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.Circulation 1987;75:331–339.
Auffermann W, Wu ST, Parmley WW, Wikman-Coffelt J, Mason DT. Influence of positive inotropic agents on [Ca2+]i: Normal rat heart.Am Heart J 1989;118:1219–1227.
Wu ST, Kojima S, Parmley WW, Wikman-Coffelt J. Relationship between cytosolic calcium and oxygen-consumption in isolated rat hearts.Cell Calcium 1992;13:235–247.
Buser PT, Camacho SA, Wu ST, et al. the effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: A13P MRS study.am Heart J 1989;117:86–90.
Auffermann W, Buser P, Wu ST, Parmley WW, Wikman-Coffelt J. Activation of glycolysis with isoproterenol but not digoxin reverses chronic alcohol depression in hamster hearts.Alcohol Clin Exp Res 1992;16:505–510.
Proschek L, Jasmin G. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic change in relation to defective mitochondrial function.Muscle Nerve 1982;5:26–32.
Wikman-Coffelt J, Sievers R, Coffelt RJ, Parmley WW. The cardiac cycle: Regulation and energy oscillations.Am J Physiol 1983;245:H354-H362.
Wikman-Coffelt J, Coffelt RJ, Rapcsak M, Sievers R, Rouleau JL, Parmley WW. A new apex-ejecting perfused rat heart preparation. Relation between coronary flow and loading conditions.Cardiovasc Res 1983;17:747–756.
Stefenelli T, Wu ST, Parmley WW, Mason DT, Wikman-Coffelt J. Influence of positive inotropic agents on intracellular calcium transient. Part II. Cardiomyopathic hamster heart.Am Heart J 1989;118:1228–1236.
Norgaard A, Bagger JP, Bjerregaard P, Baandrup U, Kjeldsen K, Thomsen PEB. Relation of left ventricular function and Na,K-pump concentration in suspected idiopathic dilated cardiomyopathy.Am J Cardiol 1988;61:1312–1315.
Auffermann W, Wu ST, Parmley WW, Wikman-Coffelt J.31P-Magnetic resonance spectroscopy of pressure overload hypertrophy: Effect of reduced perfusion pressure.Cardiovasc Res 1990;24:57–64.
Auffermann W, Camacho SA, Wu ST, et al. P-31 an H-1 magnetic resonance spectroscopy of acute alcohol cardiac depression in rats.Magn Reson Med 1988;8:58–69.
Auffermann W, Wu ST, Parmley WW, Higgins CB, Sievers R, Wikman-Coffelt J. Reversibility of acute alcohol cardiac depression. P-31 NMR in hamsters.FASEB J 1988;2:256–263.
Auffermann W, Wagner S, Wu ST, Buser P, Parmley WW, Wikman-Coffelt J. Calcium inhibition of glycolysis contributes to ischemic injury.Cardiovasc Res 1990;24:510–520.
Buser P, Wikman-Coffelt J, Wu ST, Derugin N, Parmley WW, Higgins CB. Verapamil preserves myocardial performance and energy metabolism in left ventricular hypertrophy following ischemia and reperfusion: A31P MRS study.Circulation 1989;80:1837–1845.
Buser PT, Wagner S, Wu S, Higgins CB, Wikman-Coffelt J. Protective effects of calcium antagonists on energy and substrate metabolism during ischemia and reperfusion in hypertensive myocardial hypertrophy.J Cardiovasc Pharmacol 1991;18(Suppl 10):87–92.
Lawson JRW, Veech RL. Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions.J Biol Chem 1979;254:6528–6531.
Seo Y, Murakami M, Watari H, et al. Intracellular pH determination by p-31 NMR techniques. Dissociation constant of phosphoric acid in a biological system.Biochemistry 1983;94:729–734.
Nemeth EF, Carafoli E. The role of extracellular calcium in the regulation of intracellular calcium and cell function.Cell Calcium 1990;11:319–321.
Watters TA, Botvinick EH, Parmley WW, Wu ST, Wikman-Coffelt J. Chemomechanics of altered perfusion pressure.Basic Res Cardiol 1988;83:32–42.
Wahl M, Lucherini MJ, Grünstein E. Intracellular Ca2+ measurement with Indo-1 in substrate-attached cells: Advantages and special considerations.Cell Calcium 1990;11:487–500.
Lorell BH, Apstein CS, Cunningham MJ, et al. Contribution of endothelial cells to calcium-dependent hearts loaded with Indo-1.Circ Res 1990;67:415–425.
Wagner S, Wu ST, Parmley WW, Wikman-Coffelt J. Influence of ischemia on [Ca2+]i transients following drug therapy in hearts from aortic constricted rats.Cell Calcium 1990;11:431–444.
Mayr G. Interaction of calmodulin with muscle phosphofructokinase.Eur J Biochem 1984;143:513–520.
Opie LH, Walpoth B, Barsacchi R. Calcium and catecholamines: Relevance to cardiomyopathies and significance in therapeutic strategies.J Mol Cell Cardiol 1985;17(Suppl 2):21–34.
Katz AM. Interplay between inotropic and lusitropic effects of cyclic adenosine monophosphate on the myocardial cell.Circulation 1990;82(Suppl I):I7-I11.
Author information
Authors and Affiliations
Additional information
Supported in part by the George D. Smith Foundation and NIH grant AA 07413-01. Peter Buser is a recipient of a Career Development Grant (SCORE # 32-29340,90) from the Swiss National Science Foundation.
Rights and permissions
About this article
Cite this article
Buser, P.T., Wu, S.Y., Parmley, W.W. et al. Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts. Cardiovasc Drug Ther 9, 151–157 (1995). https://doi.org/10.1007/BF00877756
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00877756